With $496 million in capital commitments, Eir Partners, a middle-market private equity company located in Miami, Florida, has announced the full completion of its second investment program, which is focused on healthcare technology and tech-enabled service.
Investors
- financial institutions
- insurance providers
- family offices
- funds-of-funds
- endowments
- foundations
- seasoned business leaders
In addition to accretive M&A possibilities, firms with proven market fit and scale that have enormous organic development potential will continue to be the focus of Eir Partners Investment Program II. The company looks to collaborate with companies where its network of senior advisors and operational expertise may have a significant influence on all facets of the organization, including finance, sales, technology, and human resources.
About Eir Partners
Private equity company Eir Partners Capital is solely committed to healthcare technology and tech-enabled services. Growth equity via control buyouts is one of the investment phases that are targeted, and equity checks vary in size from $25 to $100 million. The company has conducted payer, provider, employer, and pharmaceutical technology transactions since its founding, working with well-known brands in the sector as Apixio, Capta, GiftHealth, Helpware, and ReviveHealth.
For its first program, which completed in 2021 and invested in five platform projects, Eir previously secured $255 million in cash commitments.